phorbol 12,13-dibutyrate has been researched along with dihydropyridines in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyata, N; Otomo, S; Tsuchida, K | 1 |
Johnson, MS; MacEwan, DJ; Mitchell, R; Thomson, FJ | 1 |
Conn, PJ; Macek, TA; Schaffhauser, H | 1 |
Chartier, D; Ehrlich, JR; Hébert, TE; Nattel, S; Qi, X; Yeh, YH | 1 |
4 other study(ies) available for phorbol 12,13-dibutyrate and dihydropyridines
Article | Year |
---|---|
Protein kinase C-mediated contraction in rabbit aorta is inhibited by CD-349, a dihydropyridine derivative.
Topics: Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Calcium Channel Blockers; Cyclic AMP; Dihydropyridines; Endothelins; Male; Muscle Contraction; Nitroglycerin; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rabbits | 1991 |
The involvement of dihydropyridine-sensitive calcium channels in phorbol ester-induced luteinizing hormone and growth hormone release.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Animals; Calcium; Calcium Channels; Dihydropyridines; Female; Growth Hormone; Ion Channel Gating; Isoquinolines; Luteinizing Hormone; Phorbol 12,13-Dibutyrate; Piperazines; Pituitary Gland, Anterior; Protein Kinase C; Rats; Rats, Wistar; Staurosporine | 1993 |
Activation of PKC disrupts presynaptic inhibition by group II and group III metabotropic glutamate receptors and uncouples the receptor from GTP-binding proteins.
Topics: Adenosine; Animals; Dihydropyridines; Enzyme Activation; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Phorbol 12,13-Dibutyrate; Phorbols; Propionates; Protein Kinase C; Receptor, Adenosine A3; Receptors, Metabotropic Glutamate; Receptors, Purinergic P1; Synaptic Transmission | 1999 |
Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes.
Topics: Acetylcholine; Action Potentials; Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Bee Venoms; Clonidine; Cyclic AMP-Dependent Protein Kinases; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Estrenes; Heart Atria; Imidazoles; Indoles; Isoproterenol; Isoquinolines; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Phenylephrine; Phorbol 12,13-Dibutyrate; Piperazines; Potassium Channels; Prazosin; Propanolamines; Propranolol; Protein Kinase C; Pyrrolidinones; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Sulfonamides; Type C Phospholipases | 2007 |